Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Beta-hydroxy-beta-methylbutyrate (HMB) Supplementation After Liver Transplantation: Randomized and Controlled Pilot Study

NCT03234920 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT03234920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03234920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Beta-hydroxy-beta-methylbutyrate (HMB) Supplementation After Liver Transplantation: Randomized and Controlled Pilot Study
Lead sponsor
University of Roma La Sapienza
Phase
Not applicable
Overall status
Completed
Start date
September 25, 2015
Completion date
September 15, 2018
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcopenia